288 related articles for article (PubMed ID: 18004775)
1. Human uroporphyrinogen III synthase: NMR-based mapping of the active site.
Cunha L; Kuti M; Bishop DF; Mezei M; Zeng L; Zhou MM; Desnick RJ
Proteins; 2008 May; 71(2):855-73. PubMed ID: 18004775
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of human uroporphyrinogen III synthase expressed in Escherichia coli.
Omata Y; Sakamoto H; Higashimoto Y; Hayashi S; Noguchi M
J Biochem; 2004 Aug; 136(2):211-20. PubMed ID: 15496592
[TBL] [Abstract][Full Text] [Related]
3. Spectroscopic evidence for a porphobilinogen deaminase-tetrapyrrole complex that is an intermediate in the biosynthesis of uroporphyrinogen III.
Rosé S; Frydman RB; de los Santos C; Sburlati A; Valasinas A; Frydman B
Biochemistry; 1988 Jun; 27(13):4871-9. PubMed ID: 3262369
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of uroporphyrinogen III synthase from Pseudomonas syringae pv. tomato DC3000.
Peng S; Zhang H; Gao Y; Pan X; Cao P; Li M; Chang W
Biochem Biophys Res Commun; 2011 May; 408(4):576-81. PubMed ID: 21527255
[TBL] [Abstract][Full Text] [Related]
5. 19-Bromo-1-hydroxymethylbilane, a novel inhibitor of uro'gen III synthase.
Pichon C; Atshaves BP; Danso-Danquah R; Stolowich NJ; Scott AI
Bioorg Med Chem; 1994 Apr; 2(4):267-77. PubMed ID: 7922138
[TBL] [Abstract][Full Text] [Related]
6. Comparative density functional study of models for the reaction mechanism of uroporphyrinogen III synthase.
Silva PJ; Ramos MJ
J Phys Chem B; 2008 Mar; 112(10):3144-8. PubMed ID: 18281969
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of porphyrins and corrins. 1. 1H and 13C NMR spectra of (hydroxymethyl)bilane and uroporphyrinogens I and III.
Evans JN; Davies RC; Boyd AS; Ichinose I; Mackenzie NE; Scott AI; Baxter RL
Biochemistry; 1986 Feb; 25(4):896-904. PubMed ID: 3486001
[TBL] [Abstract][Full Text] [Related]
8. High performance liquid chromatographic studies of erythrocytes haem biosynthetic enzyme activities in alcoholic macrocytosis.
Wright DJ; Lim CK; Peters TJ
Biomed Chromatogr; 1990 Nov; 4(6):249-52. PubMed ID: 2289050
[TBL] [Abstract][Full Text] [Related]
9. Structure and mechanistic implications of a uroporphyrinogen III synthase-product complex.
Schubert HL; Phillips JD; Heroux A; Hill CP
Biochemistry; 2008 Aug; 47(33):8648-55. PubMed ID: 18651750
[TBL] [Abstract][Full Text] [Related]
10. Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
Sassa S; Zalar GL; Kappas A
J Clin Invest; 1978 Feb; 61(2):499-508. PubMed ID: 621286
[TBL] [Abstract][Full Text] [Related]
11. Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression.
Aizencang G; Solis C; Bishop DF; Warner C; Desnick RJ
Genomics; 2000 Dec; 70(2):223-31. PubMed ID: 11112350
[TBL] [Abstract][Full Text] [Related]
12. Human uroporphyrinogen III synthase: molecular cloning, nucleotide sequence, and expression of a full-length cDNA.
Tsai SF; Bishop DF; Desnick RJ
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7049-53. PubMed ID: 3174619
[TBL] [Abstract][Full Text] [Related]
13. Structural, thermodynamic, and mechanistical studies in uroporphyrinogen III synthase: molecular basis of congenital erythropoietic porphyria.
Fortian A; Castaño D; Gonzalez E; Laín A; Falcon-Perez JM; Millet O
Adv Protein Chem Struct Biol; 2011; 83():43-74. PubMed ID: 21570665
[TBL] [Abstract][Full Text] [Related]
14. Investigation of ligand binding and protein dynamics in Bacillus subtilis chorismate mutase by transverse relaxation optimized spectroscopy-nuclear magnetic resonance.
Eletsky A; Kienhöfer A; Hilvert D; Pervushin K
Biochemistry; 2005 May; 44(18):6788-99. PubMed ID: 15865424
[TBL] [Abstract][Full Text] [Related]
15. NMR mapping of the recombinant mouse major urinary protein I binding site occupied by the pheromone 2-sec-butyl-4,5-dihydrothiazole.
Zídek L; Stone MJ; Lato SM; Pagel MD; Miao Z; Ellington AD; Novotny MV
Biochemistry; 1999 Aug; 38(31):9850-61. PubMed ID: 10433691
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human uroporphyrinogen III synthase.
Mathews MA; Schubert HL; Whitby FG; Alexander KJ; Schadick K; Bergonia HA; Phillips JD; Hill CP
EMBO J; 2001 Nov; 20(21):5832-9. PubMed ID: 11689424
[TBL] [Abstract][Full Text] [Related]
17. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties.
Ulbrichova D; Hrdinka M; Saudek V; Martasek P
FEBS J; 2009 Apr; 276(7):2106-15. PubMed ID: 19292878
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of human uroporphyrinogen decarboxylase.
Whitby FG; Phillips JD; Kushner JP; Hill CP
EMBO J; 1998 May; 17(9):2463-71. PubMed ID: 9564029
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of congenital erythropoietic porphyria.
Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
[TBL] [Abstract][Full Text] [Related]
20. A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.
Phillips JD; Bergonia HA; Reilly CA; Franklin MR; Kushner JP
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5079-84. PubMed ID: 17360334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
